GAENSEL ENERGY GROUP, INC.

________________________

FIRST QUARTER REPORT

FOR THE PERIOD ENDING

March 31, 2022

OTC Markets Group Inc.

OTC Pink Basic Disclosure Guidelines (v3 February 2021)

Page 1 of 28

Disclosure Statement Pursuant to the Pink Basic Disclosure Guidelines

Gaensel Energy Group, Inc.

57 West 200 South

Suite 300

Salt Lake City, Utah 84101

518-567-3649

www.gegrgroup.com

admin@ gegrgroup.com

SIC CODE 8099

THIRD AMENDED ANNUAL QUARTER REPORT

For the Period Ending: March 31, 2022

(the "Reporting Period")

As of March 31, 2022, the number of shares outstanding of our Common Stock was:

Common Stock:

249,094,757

As of December

31, 2021, the number of shares outstanding of our Common Stock was:

Common Stock:

324,094,757

As of December

31, 2021, the most Recent Completed Fiscal Year End Date, the number of shares outstanding of our

Common Stock:

324,094,757

OTC Markets Group Inc.

OTC Pink Basic Disclosure Guidelines (v3 February 2021)

Page 2 of 28

Indicate by check mark whether the company is a shell company (as defined in Rule 405 of the Securities Act of 1933 and Rule 12b-2 of the Exchange Act of 1934):

Yes:

No:

Indicate by check mark whether the company's shell status has changed since the previous reporting period:

Yes:

No:

Indicate by check mark whether a Change in Control1 of the company has occurred over this reporting period:

Yes:

No:

  1. Name and address(es) of the Issuer and its predecessors (if any)

In answering this item, provide the current name of the Issuer any names used by predecessor entities, along with the dates of the name changes.

We, the Issuer, was founded in March 28, 1994 and its name was National Health Scan, Inc.. On February 27, 2006 the name was changed to Global Monitoring Systems, Inc. and On November 18, 2014 the name was returned to National Health Scan, Inc.

In February 2015, the name was changed to the current name, Gaensel Energy, Group, Inc.

The state of incorporation or registration of the Issuer and of each of its predecessors (if any) during the past five years; Please also include the Issuer's current standing in its state of incorporation (e.g. active, default, inactive):

The Issuer was founded in March 28, 1994 and its name was National Health Scan, Inc.. On February 27, 2006 the name was changed to Global Monitoring Systems, Inc. and On November 18, 2014 the name was returned to National Health Scan, Inc.

In February 2015, the name was changed to the current name, Gaensel Energy, Group, Inc. The Company is currently active with the Secretary of State of Nevada.

The Company current standing in its state of incorporation, Nevada, is Active and Business License renewed through March 31, 2022.

Describe any trading suspension orders issued by the SEC concerning the Issuer or its predecessors since inception:

NONE

1 "Change in Control" shall mean any events resulting in:

  1. Any "person" (as such term is used in Sections 13(d) and 14(d) of the Exchange Act) becoming the "beneficial owner" (as defined in Rule 13d-3 of the Exchange Act), directly or indirectly, of securities of the Company representing fifty percent (50%) or more of the total voting power represented by the Company's then outstanding voting securities;
  2. The consummation of the sale or disposition by the Company of all or substantially all of the Company's assets;
  3. A change in the composition of the Board occurring within a two (2)-year period, as a result of which fewer than a majority of the directors are directors immediately prior to such change; or
  4. The consummation of a merger or consolidation of the Company with any other corporation, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity or its parent) at least fifty percent (50%) of the total voting power represented by the voting securities of the Company or such surviving entity or its parent outstanding immediately after such merger or consolidation.

OTC Markets Group Inc.

OTC Pink Basic Disclosure Guidelines (v3 February 2021)

Page 3 of 28

List any stock split, stock dividend, recapitalization, merger, acquisition, spin-off, or reorganization either currently anticipated or that occurred within the past 12 months:

On October 28, 2020, the Issuer finalized its agreement for 80% of VR Metro Studio LLC, https://metrovrstudios.com), of Boston, Massachusetts. Metro VR Studios is an independent VR development company located in Boston, Massachusetts focused on developing high- quality, character-driven action & adventure games for virtual reality on Oculus, Vive and PS4.

On October 28, 2020, the Issuer completed an Agreement with Petit Chateau, S.R.L. for a majority ownership in the Company and its significant green energy projects in Italy and the additional of Mr. Labianca to our Board. The management provided the Issuer with updates which we reported for contracts being completed prior to the end of the Fiscal year. Unfortunately, the majority shareholder of Petit Chateau, S.R.L., founder Michael Labianca and his family have not provided any communication with the Issuer since January 2021. As of June 30, 2021, the Issuer has terminated the agreement with Petit Chateau, S.R.L, and did not issue the shares pursuant to the written agreement. In the meantime, the Issuer acquired the majority interest in Filmilan SRL, Italy which is developing the similar contracts in Italy. The management of Filmilan are working to continue the dialog with the remaining management of Petit Chateau and potentially revitalize the agreements with the Issuer directly or through Filmilan.

In the 4th Quarter of 2021, all joint ventures with Filmilan and Petit Chateau were terminated. The Issuer had facilitated two additional contracts into our joint venture. The Issuer's management believe these contracts will generate a substantial revenue in 2022 to compensate for Filmilan/Petit agreements.

On January 15, 2021, the Issuer finalized its agreement for an initial 30% with an option for an additional 20% of SSCB Swiss Stem Cell Biotech, Switzerland, https://www.sscb-stembiotech.com/en/. SSCB was founded as a private bank for the cryopreservation of human stem cells obtained from blood and cord tissue for both autologous and allogeneic intra-family use. SSCB also allows the preservation of stem cells from adipose tissue. These cells have great potential in regenerative medicine, thanks to their ability to differentiate into numerous cell types and thus reconstruct many compromised tissues and organs.

SSCB operates in the field of cellular therapies with specialization in the collection, purification, characterization, processing and storage of stem cells for therapeutic and aesthetic uses and for the development of new experimental protocols.

Thanks to the constant commitment in biotechnology in the cellular field, over the years a highly specialized know-how and cutting-edge methods in the processes, quality and safety of stem cell storage and release have been developed.

On January 15, 2021, the Issuer finalized its agreement for an initial 30% with an option for an additional 20% of Re-You Suisse, Switzerland, https://reyouswisse.com/. RE-YOU SUISSE is an innovative Swiss star-up that brings the excellence of regenerative medicine throughout Europe. RE-YOU SUISSE deals with regenerative medicine, a branch of medicine that aims to repair damaged tissue through cell regeneration and not replacement. It is based on the use of stem cells, which are distinguished from other cells because they have the ability to regenerate and specialize. The know-how of RE-YOU SUISSE allows the creation of centers for regenerative medicine treatments based on the use of stem cells, aesthetic medicine and plastic surgery, orthopedics, cosmetics and nutrition.

On January 17, 2021, the Issuer finalized its agreement for 65% % of Simeti Group Limited, https://www.simeti.co.uk/, Czech Republic and London, England, which includes all of Simeti's technology, intellectual property and subsidiaries. Gaensel groups has also announced that it will provide more details during the rollout period. Simeti's solutions included, but are not limited to: wind turbines installed on the building roofs, PV2 panels on the rood, water treatment, LENR3 cells ( battery storage ), and a highly portable energy container.

On January 17, 2021, the Issuer finalized its agreement to acquire 10% of ILDA AG Investment Ltd, http://ildaag.eu/, London, England. ILDA is an International Conglomerate for Commodities. The Company primary business consists of over 100 years in Coffee and Cacao throughout Colombia and South America, ILDA has extensive networks for other products in South America including petroleum, live stock, renewable energy and shipping. Gaensel Energy and ILDA Investments have developed a mutual investment to manage the Coffee Division and long term trading of Coffee Commodities

On January 21, 2021, the Issuer finalized its agreement for 50% of Oversky SL, http://www.oversky.es/, Tenerife, Spain, including its intellectual property. Oversky has been actively developing and producing a wide range of products and services

OTC Markets Group Inc.

OTC Pink Basic Disclosure Guidelines (v3 February 2021)

Page 4 of 28

in the digital marketing sector. The company aims to offer a functional and flexible strategic vision that could thrive in a constantly changing environment. Oversky mainly focuses on mobile marketing, online engagement, communication assessment, performance marketing, advertising and planning, and database building. The company works with some huge names, such as Vodafone, Ikea, Enel, Mercedes-Benz, Nissan, and Nestle. Oversky is bases in Los Realejos, Tenerife, Spain.

On January 21, 2021, the Issuer finalized its agreement for 50% of Officina Della Cialda, SRL, https://officinadellacialda.it/, Verolanuova, Italy. OFFICINA DELLA CIALDA born in 2016 from the passion for the Italian coffee. It produces and distributes capsules and waffles with selected and excellent coffee mixtures. OFFICINA DELLA CIALDA is well known for the unic aromas and flavors that only Italian roasting can boast. OFFICINA DELLA CIALDA offers capsules and waffles that can conserve coffee aroma and preserve quality. In 2019 the Company acquired a B2B web portal waffles (www.caffecenter.it) whit an average sale on line to more than 1,200 retailer customers just in Italy.

On January 29, 2021, the Issuer finalized its agreement for 50% of Angelo Caroli SRL, https://angelocaroli.com/it/, Milan, Italy. Angelo Caroli operated in the luxury made-in-Italy sector, developing and marketing a diverse array of products, such as fragrances, skincare products, eyeglasses, personal shoes, and others. Angelo Caroli, the founder of the company, has more than a decade of experience in the industry. Since 2000, the company has opened multiple wellness centers at various prestigious hotels around the world. In 2010, the company launched its own cosmetic line. Angelo Caroli has recently announced that they are prepared to enter the prestigious Middle Eastern markets, more specifically, the United Arab Emirates, where it will showcase the entire collection of luxury products, including scented candles, amenities for hotels, skincare, home fragrances, hair care, exclusive fragrances, and other. Marriott corporation in February of 2021 has signed with Angelo Caroli to carry its amenities for hotels in its presidential suites in Egypt.

On February 13, 2021, , the Issuer finalized its agreement for 50% of Europa93 SRL, http://www.europa93.com/, Milan, Italy. Europa 93 Coffee Industry is synonymous with capsules, coffee blends and much more. Sergio Dalla Riva is, in 1973, one of the pioneers in Italy in the automatic distribution sector. In 1993, thanks to the experience gained, he founded the company which is among the first to offer coffee, infusions and solubils in capsules. Europa 93 is able to provide a complete service to its Customers: from the roasting of coffee, to the production of coffee capsules with the relative customization of the capsules, up to the production of machines for domestic and professional use. The rapid and constant evolution of the market has led us to expand the proposed range, including the most popular capsule formats on the market today.

On February 20, 2021, , the Issuer finalized its agreement for 50% of Suite 110 , Milan, Italy. Suite 110 SRL provides a complete CRM management, sales and marketing system, encrypted cloud storage for secure documents, project management and a host of other features that provide businesses with a platform that simplifies operations in a single secure platform.

On February 20, 2021, , the Issuer finalized its agreement for 50% of Forom SRL, Milan, Italy. FOROM srl operates in particular in the advanced tertiary sector of civil construction, with acquisitions in the form of GENERAL CONTRACTOR by virtue of proven performance, aimed at total quality and maximum speed in execution time.

On February 20, 2021, , the Issuer finalized its agreement for 50% of Italpose SRL, Milan, Italy. Ital Pose srl is a traditional construction company specialized on renovation of buildings and commercial real estate. The company is organized with a project department, construction team and financial support assistance to clients that are looking for new energy complementary grants and financing.

On February 26, 2021, , the Issuer finalized its agreement for 50% of Bottega Del Caffe SRL, https://www.bottegadelcaffe.net/,Milan, Italy. Bottega del caffè is the new E-Commerce of Bottega Del Caffè SRL dedicated to the retail and wholesale of coffee pods and coffee capsules and hot drinks of the best brands, both original and compatible with the addition of its own brand that enhances quality and convenience. Bottega del caffè SRL operates in the e-commerce sector both as a private supplier for the user and as a sole supplier to other owners of coffee shops, guaranteeing affordable prices. Compatible pods and capsules of the most important brands on the market are available, such as Nescafè, Nespresso, Illy, Bialetti, Kimbo, Gimoka, Borbone, Toda, Caffitaly and Bottega del caffè.

On March 23, 2021, the Issuer finalized an agreement with ISCOM SPA, a holding company based in Pescantina, Italy. Subsequent to the agreement, the Issuer, Gaensel Energy Group Inc., in order to avoid possible financial undisclosed risks and incurred encumbrances, acquired control of the following ISCOM's related activities:

OTC Markets Group Inc.

OTC Pink Basic Disclosure Guidelines (v3 February 2021)

Page 5 of 28

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

National Health Scan published this content on 20 May 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 20 May 2022 15:14:02 UTC.